{"id":3118,"date":"2022-04-04T17:18:53","date_gmt":"2022-04-04T15:18:53","guid":{"rendered":"http:\/\/www.internalmed-journal.in.ua\/?p=3118"},"modified":"2022-08-24T21:59:54","modified_gmt":"2022-08-24T19:59:54","slug":"%d0%bc%d1%96%d0%be%d0%ba%d0%b0%d1%80%d0%b4%d0%b8%d1%82-%d0%b0%d1%81%d0%be%d1%86%d1%96%d0%b9%d0%be%d0%b2%d0%b0%d0%bd%d0%b8%d0%b9-%d1%96%d0%b7-%d1%96%d0%bd%d1%84%d0%b5%d0%ba%d1%86%d1%96%d1%94%d1%8e-cov","status":"publish","type":"post","link":"http:\/\/www.internalmed-journal.in.ua\/en\/archives\/3118","title":{"rendered":"Myocarditis associated with COVID-19 infection"},"content":{"rendered":"

Prof. <\/span><\/b>\u00a0Isayeva <\/span><\/b> G<\/b>. <\/b>S.<\/b><\/span><\/p>\n

Government Institution \u201cL.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine\u201d<\/span><\/b>\u00a0<\/span><\/p>\n

The article summarizes current data on the problem of myocarditis in patients with COVID-19 infection. Features of pathogenesis, risk factors, features of clinical manifestations and treatment of myocarditis are highlighted. Special attention is paid to post-vaccination myocarditis. Heterogeneity of clinical manifestations and severity of myocarditis have been demonstrated. Possible approaches and indications for anti-inflammatory therapy are considered. Management of patients with severe myocarditis requires the involvement of physicians of various specialties and decision-making when prescribing anti-inflammatory therapy with a cardiologist.<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span>Key words:<\/span><\/b> COVID-19 infection, myocarditis, glucocorticosteroids.<\/span>\u00a0<\/span><\/p>\n

https:\/\/doi.org\/10.15407\/internalmed2022.01.064<\/span><\/span>\u00a0<\/span><\/span><\/b>\u00a0<\/span><\/a><\/p>\n

Download.PDF (ukr)<\/span><\/b>\u00a0<\/span><\/a><\/p>\n

For cite:<\/span><\/b>\u00a0<\/span><\/p>\n

\u0406\u0441\u0430\u0454\u0432\u0430, \u0413.\u0421. \u041c\u0456\u043e\u043a\u0430\u0440\u0434\u0438\u0442, \u0430\u0441\u043e\u0446\u0456\u0439\u043e\u0432\u0430\u043d\u0438\u0439 \u0456\u0437 \u0456\u043d\u0444\u0435\u043a\u0446\u0456\u0454\u044e <\/span>COVID<\/span>-19 \/\/ \u0421\u0445\u0456\u0434\u043d\u043e\u0454\u0432\u0440\u043e\u043f\u0435\u0439\u0441\u044c\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0432\u043d\u0443\u0442\u0440\u0456\u0448\u043d\u044c\u043e\u0457 \u0442\u0430 \u0441\u0456\u043c\u0435\u0439\u043d\u043e\u0457 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0438. – 2022. – \u2116 1. – \u0421. 64-68. <\/span>doi<\/span>:\u00a0\u00a010.15407\/internalmed2022.01.064\u00a0 <\/span>\u00a0<\/span><\/p>\n

Isaeva GS. Miokardyt, asotsiiovanyi iz infektsiieiu COVID-19. [Myocarditis associated with COVID-19 infection]. Shidnoevr<\/span>. <\/span>z<\/span>. <\/span>vnutr<\/span>. <\/span>simejnoi<\/span> med<\/span>. 2022;1:<\/span>64<\/span>-68. <\/span>Ukrainian<\/span>. <\/span>doi<\/span>: 10.15407\/internalmed2022.01.064\u00a0 <\/span>\u00a0<\/span><\/p>\n

References:<\/span><\/b>\u00a0<\/span><\/p>\n

    \n
  1. Garg P, Arora U, Kumar A, Wig N. The \u201cpost\u2010COVID\u201d syndrome: How deep is the damage?. Journal of Medical Virology. 2020;93(2):673-674. http:\/\/dx.doi.org\/10.1002\/jmv.26465<\/li>\n
  2. Zeng J, Liu Y, Yuan J, Wang F, Wu W, Li J, Wang L, Gao H, Wang Y, Dong C, Li Y, Xie X, Feng C, Liu L. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773-777. http:\/\/dx.doi.org\/10.1007\/s15010-020-01424-5<\/li>\n
  3. Ammirati E, Frigerio M, Adler E, Basso C, Birnie D, Brambatti M, Friedrich M, Klingel K, Lehtonen J, Moslehi J, Pedrotti P, Rimoldi O, Schultheiss H, Tsch\u00f6pe C, Cooper L, Camici P. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy. Circulation: Heart Failure. 2020;13(11):. http:\/\/dx.doi.org\/10.1161\/circheartfailure.120.007405<\/li>\n
  4. Tymi\u0144ska A, Oziera\u0144ski K, Caforio A, Marcolongo R, Marchel M, Kap\u0142on-Cie\u015blicka A, Baritussio A, Filipiak K, Opolski G, Grabowski M. Myocarditis and inflammatory cardiomyopathy in 2021 \u2013 an update. Polish Archives of Internal Medicine. 2021;:. http:\/\/dx.doi.org\/10.20452\/pamw.16010<\/li>\n
  5. Metkus T, Sokoll L, Barth A, Czarny M, Hays A, Lowenstein C, Michos E, Nolley E, Post W, Resar J, Thiemann D, Trost J, Hasan R. Myocardial Injury in Severe COVID-19 Compared With Non\u2013COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021;143(6):553-565. http:\/\/dx.doi.org\/10.1161\/circulationaha.120.050543<\/li>\n
  6. Ali L, Mohammed I, Janjua I, Naeem M, Adeli G, Elalamy O, Alhatou M, Akhtar N, Canibano B, Iqrar A. Acute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: Incidence and Mortality. Cureus. 2021;:. http:\/\/dx.doi.org\/10.7759\/cureus.18899<\/li>\n
  7. Navaratnarajah C, Pease D, Halfmann P, Taye B, Barkhymer A, Howell K, Charlesworth J, Christensen T, Kawaoka Y, Cattaneo R, Schneider J. Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition. 2021;:. http:\/\/dx.doi.org\/10.1101\/2021.07.30.454437<\/li>\n
  8. Bojkova D, Wagner J, Shumliakivska M, Aslan G, Saleem U, Hansen A, Lux\u00e1n G, G\u00fcnther S, Pham M, Krishnan J, Harter P, Ermel U, Frangakis A, Milting H, Zeiher A, Klingel K, Cinatl J, Dendorfer A, Eschenhagen T, Tsch\u00f6pe C, Ciesek S, Dimmeler S. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovascular Research. 2020;116(14):2207-2215. http:\/\/dx.doi.org\/10.1093\/cvr\/cvaa267<\/li>\n
  9. Bulfamante G, Perrucci G, Falleni M, Sommariva E, Tosi D, Martinelli C, Songia P, Poggio P, Carugo S, Pompilio G. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement. Biomedicines. 2020;8(12):626. http:\/\/dx.doi.org\/10.3390\/biomedicines8120626<\/li>\n
  10. Kaya H, Asoglu R, Afsin A, Tibilli H, Kurt E, Kafadar S, Gulacti U, Kafadar H. The evaluation of myocardial performance index in patients with COVID-19: An echocardiographic follow-up study. European Heart Journal – Cardiovascular Imaging. 2021;22(Supplement_1):. http:\/\/dx.doi.org\/10.1093\/ehjci\/jeaa356.100<\/li>\n
  11. Agdamag A, Edmiston J, Charpentier V, Chowdhury M, Fraser M, Maharaj V, Francis G, Alexy T. Update on COVID-19 Myocarditis. Medicina. 2020;56(12):678. http:\/\/dx.doi.org\/10.3390\/medicina56120678<\/li>\n
  12. Shchendrygina A, Nagel E, Puntmann V, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Review of Cardiovascular Therapy. 2020;19(1):5-14. http:\/\/dx.doi.org\/10.1080\/14779072.2021.1844005<\/li>\n
  13. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post\u2010COVID\u201019 manifestations. International Journal of Clinical Practice. 2020;75(3):. http:\/\/dx.doi.org\/10.1111\/ijcp.13746<\/li>\n
  14. Han H, Yang L, Liu R, Liu F, Wu K, Li J, Liu X, Zhu C. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(7):1116-1120. http:\/\/dx.doi.org\/10.1515\/cclm-2020-0188<\/li>\n
  15. Guzik T, Mohiddin S, Dimarco A, Patel V, Savvatis K, Marelli-Berg F, Madhur M, Tomaszewski M, Maffia P, D\u2019Acquisto F, Nicklin S, Marian A, Nosalski R, Murray E, Guzik B, Berry C, Touyz R, Kreutz R, Wang D, Bhella D, Sagliocco O, Crea F, Thomson E, McInnes I. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020;116(10):1666-1687. http:\/\/dx.doi.org\/10.1093\/cvr\/cvaa106<\/li>\n
  16. Sandoval Y, Januzzi J, Jaffe A. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19. Journal of the American College of Cardiology. 2020;76(10):1244-1258. http:\/\/dx.doi.org\/10.1016\/j.jacc.2020.06.068<\/li>\n
  17. Peretto G, Sala S, Rizzo S, De Luca G, Campochiaro C, Sartorelli S, Benedetti G, Palmisano A, Esposito A, Tresoldi M, Thiene G, Basso C, Della Bella P. Arrhythmias in myocarditis: State of the art. Heart Rhythm. 2019;16(5):793-801. http:\/\/dx.doi.org\/10.1016\/j.hrthm.2018.11.024<\/li>\n
  18. Lozano G\u00f3mez H, Pascual Bielsa A, Arche Banzo M. Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection. Medicina Cl\u00ednica (English Edition). 2020;155(10):463-464. http:\/\/dx.doi.org\/10.1016\/j.medcle.2020.07.012<\/li>\n
  19. Irabien-Ortiz \u00c1, Carreras-Mora J, Sionis A, P\u00e0mies J, Montiel J, Tauron M. Miocarditis fulminante por COVID-19. Revista Espa\u00f1ola de Cardiolog\u00eda. 2020;73(6):503-504. http:\/\/dx.doi.org\/10.1016\/j.recesp.2020.04.001<\/li>\n
  20. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):811. http:\/\/dx.doi.org\/10.1001\/jamacardio.2020.1017<\/li>\n
  21. Onderko L, Starobin B, Riviere A, Hohl P, Phillips C, Morgan R, Welsh A, Francis S, Afari M. Myocarditis in the Setting of Recent COVID-19 Vaccination. Case Reports in Cardiology. 2021;2021:1-5. http:\/\/dx.doi.org\/10.1155\/2021\/6806500<\/li>\n
  22. Diaz G, Parsons G, Gering S, Meier A, Hutchinson I, Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021;326(12):1210. http:\/\/dx.doi.org\/10.1001\/jama.2021.13443<\/li>\n
  23. Al\u2010Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, Mhaimeed O, Mhaimeed N, Zeghlache R, Salameh M, Paul P, Homssi M, Mohammed I, Narangoli A, Yagan L, Khanjar B, Laws S, Elshazly M, Zakaria D. Cardiovascular and haematological events post COVID\u201019 vaccination: A systematic review. Journal of Cellular and Molecular Medicine. 2021;26(3):636-653. http:\/\/dx.doi.org\/10.1111\/jcmm.17137<\/li>\n
  24. Pepe S, Gregory A, Denniss A. Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination. Heart, Lung and Circulation. 2021;30(10):1425-1429. http:\/\/dx.doi.org\/10.1016\/j.hlc.2021.07.011<\/li>\n
  25. Mason J, O’Connell J, Herskowitz A, Rose N, McManus B, Billingham M, Moon T. A Clinical Trial of Immunosuppressive Therapy for Myocarditis. New England Journal of Medicine. 1995;333(5):269-275. http:\/\/dx.doi.org\/10.1056\/nejm199508033330501<\/li>\n
  26. Chen H, Wang W, Wu S, Liu J. Corticosteroids for viral myocarditis. Cochrane Database of Systematic Reviews. 2013;2021(4):. http:\/\/dx.doi.org\/10.1002\/14651858.cd004471.pub3<\/li>\n
  27. Caldeira D, Lopes L, Vaz-Carneiro A, Costa J. Cochrane Corner: Corticosteroids for viral myocarditis. Revista Portuguesa de Cardiologia (English Edition). 2015;34(1):65-67. http:\/\/dx.doi.org\/10.1016\/j.repce.2014.08.007<\/li>\n
  28. Kow C, Hasan S. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020;48(5):805-806. http:\/\/dx.doi.org\/10.1007\/s15010-020-01441-4<\/li>\n
  29. Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah N. A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001. JACC: Case Reports. 2020;2(9):1331-1336. http:\/\/dx.doi.org\/10.1016\/j.jaccas.2020.04.025<\/li>\n
  30. Garot J, Amour J, Pezel T, Dermoch F, Messadaa K, Felten M, Raymond V, Baubillier E, Sanguineti F, Garot P. SARS-CoV-2 Fulminant Myocarditis. JACC: Case Reports. 2020;2(9):1342-1346. http:\/\/dx.doi.org\/10.1016\/j.jaccas.2020.05.060<\/li>\n
  31. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal. 2020;42(2):206-206. http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehaa190<\/li>\n
  32. Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults. International Heart Journal. 2019;60(2):359-365. http:\/\/dx.doi.org\/10.1536\/ihj.18-299<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Prof. \u00a0Isayeva G. S. Government Institution \u201cL.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine\u201d\u00a0 The article summarizes current data on the problem of myocarditis in patients with COVID-19 infection. Features of pathogenesis, risk factors, features of clinical manifestations and treatment of myocarditis are highlighted. Special attention is paid to…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57,9,66],"tags":[],"translation":{"provider":"WPGlobus","version":"2.12.2","language":"en","enabled_languages":["uk","en","ru"],"languages":{"uk":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false},"ru":{"title":true,"content":true,"excerpt":false}}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3118"}],"collection":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/comments?post=3118"}],"version-history":[{"count":6,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3118\/revisions"}],"predecessor-version":[{"id":3242,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/3118\/revisions\/3242"}],"wp:attachment":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/media?parent=3118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/categories?post=3118"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/tags?post=3118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}